References

1. Patterson, C. World Alzheimer Report 2018—The State of the Art of Dementia Research: New Frontiers; Alzheimer’s Disease International: London, UK, 2018.
2. Geddes, M.R.; O’Connell, M.E.; Fisk, J.D.; Gauthier, S.; Camicioli, R.; Ismail, Z. Remote cognitive and behavioral assessment: Report of the Alzheimer Society of Canada Task Force on dementia care best practices for COVID-19. Alzheimer’s Dementia: Diagn. Assess. Dis. Monit. 2020, 12.
3. Loh, P.-K.; Ramesh, P.; Maher, S.; Saligari, J.; Flicker, L.; Goldswain, P. Can patients with dementia be assessed at a distance? The use of Telehealth and standardised assessments. Intern. Med. J. 2004, 34, 239–242.
4. Wadsworth, H.E.; Dhima, K.; Womack, K.B.; Hart, J.; Weiner, M.F.; Hynan, L.S.; Cullum, C.M. Validity of Teleneuropsychological Assessment in Older Patients with Cognitive Disorders. Arch. Clin. Neuropsychol. 2018, 33, 1040–1045.
5. Hwang, K.; De Silva, A.; A Simpson, J.; Logiudice, D.; Engel, L.; Gilbert, A.S.; Croy, S.; Haralambous, B. Video-interpreting for cognitive assessments: An intervention study and micro-costing analysis. J. Telemed. Telecare 2020.
6. Lindauer, A.; Seelye, A.; Lyons, B.; Dodge, H.H.; Mattek, N.; Mincks, K.; Kaye, J.; Erten-Lyons, D. Dementia Care Comes Home: Patient and Caregiver Assessment via Telemedicine. Gerontology 2017, 57, e85–e93.
7. Cheong, C.-K.; Lim, K.-H.; Jang, J.-W.; Jhoo, J.H. The effect of telemedicine on the duration of treatment in dementia patients. J. Telemed. Telecare 2015, 21, 214–218.
8. LaMantia, M.A.; Stump, T.E.; Messina, F.C.; Miller, D.K.; Callahan, C.M. Emergency Department Use Among Older Adults With Dementia. Alzheimer Dis. Assoc. Disord. 2016, 30, 35–40.
9. Gillespie, S.M.; Wasserman, E.B.; Wood, N.E.; Wang, H.; Dozier, A.; Nelson, D.; McConnochie, K.M.; Shah, M.N. High-Intensity Telemedicine Reduces Emergency Department Use by Older Adults With Dementia in Senior Living Communities. J. Am. Med. Dir. Assoc. 2019, 20, 942–946.
10. Williams, K.N.; Shaw, C.A.; Perkhounkova, Y.; Hein, M.; Coleman, C.K. Satisfaction, utilization, and feasibility of a telehealth intervention for in-home dementia care support: A mixed methods study. Dementia 2020.
11. Sethi, K.D. Clinical aspects of Parkinson disease. Curr. Opin. Neurol. 2002, 15, 457–460.
12. Ferreira, J.J.; Godinho, C.; Santos, A.T.; Domingos, J.M.M.; Abreu, D.; Lobo, R.; Gonçalves, N.; Barra, M.; Larsen, F.; Fagerbakke, Ø.; et al. Quantitative home-based assessment of Parkinson’s symptoms: The SENSE-PARK feasibility and usability study. BMC Neurol. 2015, 15, 1–7.
13. Ramsperger, R.; Meckler, S.; Heger, T.; Van Uem, J.; Hucker, S.; Braatz, U.; Graessner, H.; Berg, D.; Manoli, Y.; Serrano, J.A.; et al. Continuous leg dyskinesia assessment in Parkinson’s disease –clinical validity and ecological effect. Park. Relat. Disord. 2016, 26, 41–46.
14. Heldman, D.A.; Giuffrida, J.P.; Cubo, E. Wearable Sensors for Advanced Therapy Referral in Parkinson’s Disease. J. Park. Dis. 2016, 6, 631–638.
15. Samii, A.; Ryan-Dykes, P.; Tsukuda, R.A.; Zink, C.; Franks, R.; Nichol, W.P. Telemedicine for delivery of health care in Parkinson’s disease. J. Telemed. Telecare 2006, 12, 16–18.
16. Abdolahi, A.; Scoglio, N.; Killoran, A.; Dorsey, E.R.; Biglan, K.M. Potential reliability and validity of a modified version of the Unified Parkinson’s Disease Rating Scale that could be administered remotely. Park. Relat. Disord. 2013, 19, 218–221.
17. Cubo, E.; Mariscal, N.; Solano, B.; Becerra, V.; Armesto, D.; Calvo, S.; Arribas, J.; Seco, J.; Martinez, A.; Zorrilla, L.; et al. Prospective study on cost-effectiveness of home-based motor assessment in Parkinson’s disease. J. Telemed. Telecare 2016, 23, 328–338.
18. Dorsey, E.R.; Venkataraman, V.; Grana, M.J.; Bull, M.T.; George, B.P.; Boyd, C.M.; Beck, C.A.; Rajan, B.; Seidmann, A.; Biglan, K.M. Randomized controlled clinical trial of “virtual house calls” for Parkinson disease. JAMA Neurol. 2013, 70, 565–570.
19. Beck, C.A.; Beran, D.B.; Biglan, K.M.; Boyd, C.M.; Dorsey, E.R.; Schmidt, P.N.; Simone, R.; Willis, A.W.; Galifianakis, N.B.; Katz, M.; et al. National randomized controlled trial of virtual house calls for Parkinson disease. Neurology 2017, 89, 1152–1161.
20. Durner, G.; Durner, J.; Dunsche, H.; Walle, E.; Kurzreuther, R.; Handschu, R. 24/7 Live Stream Telemedicine Home Treatment Service for Parkinson’s Disease Patients. Mov. Disord. Clin. Pract. 2016, 4, 368–373.
21. Biglan, K.M.; Voss, T.S.; Deuel, L.M.; Miller, D.; Eason, S.; Fagnano, M.; George, B.P.; Appler, A.; Polanowicz, J.; Viti, L.; et al. Telemedicine for the care of nursing home residents with Parkinson’s disease. Mov. Disord. 2009, 24, 1073–1076.
22. Dorsey, E.R.; Deuel, L.M.; Voss, T.S.; Finnigan, K.; George, B.P.; Eason, S.; Miller, D.; Reminick, J.I.; Appler, A.; Polanowicz, J.; et al. Increasing access to specialty care: A pilot, randomized controlled trial of telemedicine for Parkinson’s disease. Mov. Disord. 2010, 25, 1652–1659.
23. Marzinzik, F.; Wahl, M.; Doletschek, C.M.; Jugel, C.; Rewitzer, C.; Klostermann, F. Evaluation of a telemedical care programme for patients with Parkinson’s disease. J. Telemed. Telecare 2012, 18, 322–327.
24. Qiang, J.; Marras, C. Telemedicine in Parkinson’s disease: A patient perspective at a tertiary care centre. Park. Relat. Disord. 2015, 21, 525–528.
25. Dorsey, E.R.; Achey, M.A.; Beck, C.A.; Beran, D.B.; Biglan, K.M.; Boyd, C.M.; Schmidt, P.N.; Simone, R.; Willis, A.W.; Galifianakis, N.B.; et al. National Randomized Controlled Trial of Virtual House Calls for People with Parkinson’s Disease: Interest and Barriers. Telemed. E Health 2016, 22, 590–598.
26. Spear, K.L.; Auinger, P.; Simone, R.; Dorsey, E.R.; Francis, J. Patient Views on Telemedicine for Parkinson Disease. J. Park. Dis. 2019, 9, 401–404.
27. Howell, S.; Tripoliti, E.; Pring, T. Delivering the Lee Silverman Voice Treatment (LSVT) by web camera: A feasibility study. Int. J. Lang. Commun. Disord. 2009, 44, 287–300.
28. Griffin, M.; Bentley, J.; Shanks, J.; Wood, C. The effectiveness of Lee Silverman Voice Treatment therapy issued interactively through an iPad device: A non-inferiority study. J. Telemed. Telecare 2018, 24, 209–215.
29. Quinn, R.; Park, S.; Theodoros, D.; Hill, A.J. Delivering group speech maintenance therapy via telerehabilitation to people with Parkinson’s disease: A pilot study. Int. J. Speech Lang. Pathol. 2018, 21, 385–394.
30. A Constantinescu, G.; Theodoros, D.; Russell, T.; Ward, E.; Wilson, S.; Wootton, R. Assessing disordered speech and voice in Parkinson’s disease: A telerehabilitation application. Int. J. Lang. Commun. Disord. 2010, 45, 630–644.
31. Gandolfi, M.; Geroin, C.; Dimitrova, E.; Boldrini, P.; Waldner, A.; Bonadiman, S.; Picelli, A.; Regazzo, S.; Stirbu, E.; Primon, D.; et al. Virtual Reality Telerehabilitation for Postural Instability in Parkinson’s Disease: A Multicenter, Single-Blind, Randomized, Controlled Trial. BioMed Res. Int. 2017, 2017, 1–11.
32. Lai, B.; Bond, K.; Kim, Y.; Barstow, B.; Jovanov, E.; Bickel, C.S. Exploring the uptake and implementation of tele-monitored home-exercise programmes in adults with Parkinson’s disease: A mixed-methods pilot study. J. Telemed. Telecare 2018, 26, 53–63.
33. Veazey, C.; Cook, K.F.; Stanley, M.; Lai, E.C.; Kunik, M.E. Telephone-Administered Cognitive Behavioral Therapy: A Case Study of Anxiety and Depression in Parkinson’s Disease. J. Clin. Psychol. Med. Settings 2009, 16, 243–253.
34. Dobkin, R.D.; Mann, S.L.; Gara, M.A.; Interian, A.; Rodriguez, K.M.; Menza, M. Telephone-based cognitive behavioral therapy for depression in Parkinson disease: A randomized controlled trial. Neurology 2020, 94, e1764–e1773.
35. Seritan, A.L.; Heiry, M.; Iosif, A.-M.; Dodge, M.; Ostrem, J.L. Telepsychiatry for patients with movement disorders: A feasibility and patient satisfaction study. J. Clin. Mov. Disord. 2019, 6, 1.
36. Willows, T.; Dizdar, N.; Nyholm, D.; Widner, H.; Grenholm, P.; Schmiauke, U.; Urbom, A.; Groth, K.; Larsson, J.; Permert, J.; et al. Initiation of Levodopa-Carbidopa Intestinal Gel Infusion Using Telemedicine (Video Communication System) Facilitates Efficient and Well-Accepted Home Titration in Patients with Advanced Parkinson’s Disease. J. Park. Dis. 2017, 7, 719–728.
37. Jitkritsadakul, O.; Rajalingam, R.; Toenjes, C.; Munhoz, R.P.; Fasano, A. Tele-health for patients with deep brain stimulation: The experience of the Ontario Telemedicine Network. Mov. Disord. 2018, 33, 491–492.
38. Pérez-López, C.; Samà, A.; Rodríguez-Martín, D.; Català, A.; Cabestany, J.; Moreno-Arostegui, J.M.; De Mingo, E.; Rodríguez-Molinero, A. Remote control of apomorphine infusion rate in Parkinson’s disease: Real-time dose variations according to the patients’ motor state. A proof of concept. Park Relat. Disord. 2015, 21, 996–998.
39. Papa, S.M.; Brundin, P.; Fung, V.S.C.; Kang, U.J.; Burn, D.J.; Colosimo, C.; Chiang, H.-L.; Alcalay, R.N.; Trenkwalder, C.; MDS-Scientific Issues Committee. Impact of the COVID-19 pandemic on Parkinson’s disease and movement disorders. Mov. Disord. 2020, 6.
40. Cilia, R.; Mancini, F.; Bloem, B.R.; Eleopra, R. Telemedicine for parkinsonism: A two-step model based on the COVID-19 experience in Milan, Italy. Park. Relat. Disord. 2020, 75, 130–132.
41. Fasano, A.; Antonini, A.; Katzenschlager, R.; Krack, P.; Odin, P.; Evans, A.H.; Foltynie, T.; Volkmann, J.; Merello, M. Management of Advanced Therapies in Parkinson’s Disease Patients in Times of Humanitarian Crisis: The COVID -19 Experience. Mov. Disord. Clin. Pract. 2020, 7, 361–372.
42. Miocinovic, S.; Ostrem, J.L.; Okun, M.S.; Bullinger, K.L.; Riva-Posse, P.; Gross, R.E.; Buetefisch, C.M. Recommendations for Deep Brain Stimulation Device Management During a Pandemic. J. Park. Dis. 2020, 10, 1–8.
43. Zhang, C.; Zhu, K.; Lin, Z.; Huang, P.; Pan, Y.; Sun, B.; Li, D. Utility of Deep Brain Stimulation Telemedicine for Patients With Movement Disorders During the COVID -19 Outbreak in China. Neuromodulation Technol. Neural Interface 2020.
44. Quinn, L.; MacPherson, C.; Long, K.; Shah, H. Promoting Physical Activity via Telehealth in People With Parkinson Disease: The Path Forward After the COVID-19 Pandemic? Phys. Ther. 2020, 100, 1730–1736.
45. Srivastav, A.K.; Samuel, A.J. E-Rehabilitation: One solution for patients with Parkinson’s disease in COVID-19 era. Park. Relat. Disord. 2020, 75, 128–129.
46. Mulroy, E.; Menozzi, E.; Lees, A.J.; Lynch, T.; Lang, A.E.; Bhatia, K.P. Telemedicine in Movement Disorders: Leçons du COVID-19. Mov. Disord. 2020, 35, 1893–1896.
47. Hobson, E.V.; Baird, W.O.; Cooper, C.L.; Mawson, S.; Shaw, P.J.; Mcdermott, C.J. Using technology to improve access to specialist care in amyotrophic lateral sclerosis: A systematic review. Amyotroph. Lateral Scler. Front. Degener. 2016, 17, 313–324.
48. Paganoni, S.; Nicholson, K.; Leigh, F.; Swoboda, K.J.; Chad, D.; Drake, K.; Haley, K.; Cudkowicz, M.; Berry, J.D. Developing multidisciplinary clinics for neuromuscular care and research. Muscle Nerve 2017, 56, 848–858.
49. Nijeweme-d’Hollosy, W.O.; Janssen, E.P.F.; Huis in ’t Veld, R.M.H.A.; Spoelstra, J.; Vollenbroek-Hutten, M.M.R.; Hermens, H.J. Tele-treatment of patients with amyotrophic lateral sclerosis (ALS). J. Telemed. Telecare 2006, 12, 31–34.
50. Van De Rijn, M.; Paganoni, S.; Levine-Weinberg, M.; Campbell, K.; Swartz Ellrodt, A.; Estrada, J.; Cohen, A.B.; Schwamm, L.H.; Berry, J.D. Experience with telemedicine in a multi-disciplinary ALS clinic. Amyotroph. Lateral Scler. Front. Degener. 2018, 19, 143–148.
51. Paganoni, S.; Van De Rijn, M.; Drake, K.; Burke, K.; Doyle, M.; Dpt, A.S.E.; Nicholson, K.; Atassi, N.; De Marchi, F.; Babu, S.; et al. Adjusted cost analysis of video televisits for the care of people with amyotrophic lateral sclerosis. Muscle Nerve 2019, 60, 147–154.
52. Selkirk, S.M.; Washington, M.O.; McClellan, F.; Flynn, B.; Seton, J.M.; Strozewski, R. Delivering tertiary centre specialty care to ALS patients via telemedicine: A retrospective cohort analysis. Amyotroph. Lateral Scler. Front. Degener. 2017, 18, 324–332.
53. Amato, S.; Poliandri, G.; Sgroi, D.; Clarici, L.; De Salazar, V. [Telemedicine and improvement in care quality. The experience of Rome 3 Healthcare Local Autority in home care of patients with amyotrophic lateral sclerosis (ALS)]. Ig. Sanita Pubbl. 2020, 75, 371–376.
54. Hobson, E.V.; Baird, W.O.; Partridge, R.; Cooper, C.L.; Mawson, S.; Quinn, A.; Shaw, P.J.; Walsh, T.; Wolstenholme, D.; Mcdermott, C.J. The TiM system: Developing a novel telehealth service to improve access to specialist care in motor neurone disease using user-centered design. Amyotroph. Lateral Scler. Front. Degener. 2018, 19, 351–361.
55. Helleman, J.; Van Eenennaam, R.; Kruitwagen, E.T.; Kruithof, W.J.; Slappendel, M.J.; Berg, L.H.V.D.; Visser-Meily, J.M.; Beelen, A. Telehealth as part of specialized ALS care: Feasibility and user experiences with “ALS home-monitoring and coaching”. Amyotroph. Lateral Scler. Front. Degener. 2020, 21, 183–192.
56. Wills, A.M.; Garry, J.; Hubbard, J.; Mezoian, T.; Breen, C.T.; Ortiz-Miller, C.; Nalipinski, P.; Sullivan, S.; Berry, J.D.; Cudkowicz, M.E.; et al. Nutritional counseling with or without mobile health technology: A randomized open-label standard-of-care-controlled trial in ALS. BMC Neurol. 2019, 19, 1–9.
57. Vitacca, M.; Comini, L.; Tentorio, M.; Assoni, G.; Trainini, D.; Fiorenza, D.; Morini, R.; Bruletti, G.; Scalvini, S. A pilot trial of telemedicine-assisted, integrated care for patients with advanced amyotrophic lateral sclerosis and their caregivers. J. Telemed. Telecare 2010, 16, 83–88.
58. Vitacca, M.; Comini, L.; Assoni, G.; Fiorenza, D.; Gilè, S.; Bernocchi, P.; Scalvini, S. Tele-assistance in patients with amyotrophic lateral sclerosis: Long term activity and costs. Disabil. Rehabilitation: Assist. Technol. 2012, 7, 494–500.
59. Pinto, A.C.; Almeida, J.P.; Pinto, S.C.; Pereira, J.; Oliveira, A.G.; De Carvalho, M. Home telemonitoring of non-invasive ventilation decreases healthcare utilisation in a prospective controlled trial of patients with amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 2010, 81, 1238–1242.
60. de Almeida, J.P.L.; Pinto, A.C.; Pereira, J.; Pinto, S.; de Carvalho, M. Implementation of a wireless device for real-time telemedical assistance of home-ventilated amyotrophic lateral sclerosis patients: A feasibility study. Telemed E Health 2010, 16, 883–888.
61. Cousins, R.; Ashcroft-Kelso, H.; Halhead, R.; Young, C.; Chakrabarti, B.; Levene, P.; Cousins, R.; Angus, R.M. Incorporating self-reported questions for telemonitoring to optimize care of patients with MND on noninvasive ventilation (MND OptNIVent). Amyotroph. Lateral Scler. Front. Degener. 2019, 20, 336–347.
62. Bombaci, A.; Abbadessa, G.; Trojsi, F.; Leocani, L.; Bonavita, S.; Lavorgna, L. Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail. Neurol. Sci. 2021, 42, 9–13.
63. Andrews, J.A.; Berry, J.D.; Baloh, R.H.; Carberry, N.; Cudkowicz, M.E.; Dedi, B.; Glass, J.; Maragakis, N.J.; Miller, T.M.; Paganoni, S.; et al. Amyotrophic Lateral Sclerosis Care and Research in the USA During the COVID-19 Pandemic: Challenges and Opportunities. Muscle Nerve 2020, 62, 182–186.
64. Capozzo, R.; Zoccolella, S.; Musio, M.; Barone, R.; Accogli, M.; Logroscino, G. Telemedicine is a useful tool to deliver care to patients with Amyotrophic Lateral Sclerosis during COVID-19 pandemic: Results from Southern Italy. Amyotroph. Lateral Scler. Front. Degener. 2020, 21, 542–548.
65. Vasta, R.; Moglia, C.; D’Ovidio, F.; Di Pede, F.; De Mattei, F.; Cabras, S.; Peotta, L.; Iazzolino, B.; Giusiano, S.; Manera, U.; et al. Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: An Italian ALS referral center experience. Amyotroph. Lateral Scler. Front. Degener. 2020, 1–4.
66. De Marchi, F.; Sarnelli, M.F.; Serioli, M.; De Marchi, I.; Zani, E.; Bottone, N.; Ambrosini, S.; Garone, R.; Cantello, R.; Mazzini, L. Telehealth approach for amyotrophic lateral sclerosis patients: The experience during COVID-19 pandemic. Acta Neurol. Scand. 2020.
67. De Marchi, F.; Cantello, R.; Ambrosini, S.; Mazzini, L.; Group, C.S. Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19. Neurol. Sci. 2020, 41, 1365–1367.
68. Manera, U.; Cabras, S.; Daviddi, M.; Vasta, R.; Torrieri, M.C.; Palumbo, F.; Bombaci, A.; Grassano, M.; Solero, L.; Peotta, L.; et al. Validation of the Italian version of self-administered ALSFRS-R scale. Amyotroph. Lateral Scler. Front. Degener. 2020, 1–3, 1–3.
69. Bassan, S. Data privacy considerations for telehealth consumers amid COVID-19. J. Law Biosci. 2020, 7, lsaa075.
70. Raposo, V.L. Telemedicine: The legal framework (or the lack of it) in Europe. GMS Health Technol Assess 2016, 12.
71. Grossman, S.N.; Han, S.C.; Balcer, L.J.; Kurzweil, A.; Weinberg, H.; Galetta, S.L.; Busis, N.A. Rapid implementation of virtual neurology in response to the COVID-19 pandemic. Neurology 2020, 94, 1077–1087.
72. Govindarajan, R.; Berry, J.D.; Paganoni, S.; Pulley, M.T.; Simmons, Z. Optimizing telemedicine to facilitate amyotrophic lateral sclerosis clinical trials. Muscle Nerve 2020, 62, 321–326.